Neonatal pharmacology: rational therapeutics for the most vulnerable.
作者信息
James L, Ito S
出版信息
Clin Pharmacol Ther. 2009 Dec;86(6):573-7. doi: 10.1038/clpt.2009.212.
Abstract
摘要
相似文献
1
Neonatal pharmacology: rational therapeutics for the most vulnerable.新生儿药理学：针对最脆弱群体的合理治疗方法。
Clin Pharmacol Ther. 2009 Dec;86(6):573-7. doi: 10.1038/clpt.2009.212.
2
Sustained neurobehavioral effects of exposure to SSRI antidepressants during development: molecular to clinical evidence.发育期间暴露于选择性5-羟色胺再摄取抑制剂（SSRI）类抗抑郁药的持续神经行为影响：从分子到临床的证据
Clin Pharmacol Ther. 2009 Dec;86(6):672-7. doi: 10.1038/clpt.2009.201. Epub 2009 Nov 4.
3
The association between prenatal exposure to phthalates and cognition and neurobehavior of children-evidence from birth cohorts.孕期邻苯二甲酸酯暴露与儿童认知和神经行为的关联——来自队列研究的证据。
Neurotoxicology. 2019 Jul;73:199-212. doi: 10.1016/j.neuro.2019.04.007. Epub 2019 Apr 17.
4
[Prenatal lead exposure related to cord blood brain derived neurotrophic factor (BDNF) levels and impaired neonatal neurobehavioral development].[产前铅暴露与脐血脑源性神经营养因子（BDNF）水平及新生儿神经行为发育受损的关系]
Zhonghua Yu Fang Yi Xue Za Zhi. 2016 Jun;50(6):514-8. doi: 10.3760/cma.j.issn.0253-9624.2016.06.008.
5
Prenatal exposure to manganese at environment relevant level and neonatal neurobehavioral development.环境相关水平锰暴露对新生儿神经行为发育的影响。
Environ Res. 2014 Aug;133:232-8. doi: 10.1016/j.envres.2014.04.012. Epub 2014 Jun 25.
6
Precision therapeutics in the NICU: why are we missing the mark?新生儿重症监护病房中的精准治疗：为何我们未达目标？
J Perinatol. 2018 May;38(5):444-446. doi: 10.1038/s41372-018-0052-8. Epub 2018 Jan 29.
7
Adverse drug reactions in neonates.
J Clin Pharmacol. 1994 Feb;34(2):128-35. doi: 10.1002/j.1552-4604.1994.tb03976.x.
8
Neonatal signs after late in utero exposure to serotonin reuptake inhibitors: literature review and implications for clinical applications.宫内晚期暴露于5-羟色胺再摄取抑制剂后的新生儿体征：文献综述及临床应用启示
JAMA. 2005 May 18;293(19):2372-83. doi: 10.1001/jama.293.19.2372.
9
Neonatal signs after in utero exposure to selective serotonin reuptake inhibitors.子宫内暴露于选择性5-羟色胺再摄取抑制剂后的新生儿体征。
JAMA. 2005 Nov 9;294(18):2299-300; author reply 2300-1. doi: 10.1001/jama.294.18.2299-c.
10
The association of prenatal exposure to intensive traffic with early preterm infant neurobehavioral development as reflected by the NICU Network Neurobehavioral Scale (NNNS).产前暴露于密集交通与新生儿重症监护室网络神经行为量表（NNNS）反映的早期早产儿神经行为发育的关系。
Environ Res. 2020 Apr;183:109204. doi: 10.1016/j.envres.2020.109204. Epub 2020 Jan 31.
引用本文的文献
1
Adverse Drug Reactions in Children: Pediatric Pharmacy and Drug Safety.儿童药物不良反应：儿科药学与药物安全
J Pediatr Pharmacol Ther. 2019 Jan-Feb;24(1):4-9. doi: 10.5863/1551-6776-24.1.4.
2
Federal legislation and the advancement of neonatal drug studies.联邦立法与新生儿药物研究的进展
J Pediatr. 2013 Jan;162(1):12-5. doi: 10.1016/j.jpeds.2012.08.034. Epub 2012 Oct 27.
本文引用的文献
1
Clinical trial design in neonatal pharmacology: effect of center differences, with lessons from the Pediatric Oncology Cooperative Research experience.新生儿药理学中的临床试验设计：中心差异的影响，并借鉴儿科肿瘤协作研究的经验教训
Clin Pharmacol Ther. 2009 Dec;86(6):589-91. doi: 10.1038/clpt.2009.175.
2
Clinical trials in neonates: a therapeutic imperative.新生儿临床试验：治疗的迫切需求。
Clin Pharmacol Ther. 2009 Dec;86(6):585-7. doi: 10.1038/clpt.2009.207.
3
Sustained neurobehavioral effects of exposure to SSRI antidepressants during development: molecular to clinical evidence.发育期间暴露于选择性5-羟色胺再摄取抑制剂（SSRI）类抗抑郁药的持续神经行为影响：从分子到临床的证据
Clin Pharmacol Ther. 2009 Dec;86(6):672-7. doi: 10.1038/clpt.2009.201. Epub 2009 Nov 4.
4
Developmental pharmacogenetics: a general paradigm for application to neonatal pharmacology and toxicology.发育药物遗传学：应用于新生儿药理学和毒理学的一般范式。
Clin Pharmacol Ther. 2009 Dec;86(6):678-82. doi: 10.1038/clpt.2009.195. Epub 2009 Oct 28.
5
Clinical trial simulations in pediatric patients using realistic covariates: application to teduglutide, a glucagon-like peptide-2 analog in neonates and infants with short-bowel syndrome.使用实际协变量的儿科患者临床试验模拟：在患有短肠综合征的新生儿和婴儿中应用胰高血糖素样肽-2类似物替度鲁肽的研究
Clin Pharmacol Ther. 2009 Dec;86(6):667-71. doi: 10.1038/clpt.2009.199. Epub 2009 Oct 21.
6
Population pharmacokinetics of fluconazole in young infants.氟康唑在婴幼儿中的群体药代动力学
Antimicrob Agents Chemother. 2008 Nov;52(11):4043-9. doi: 10.1128/AAC.00569-08. Epub 2008 Sep 22.
7
Evaluation of the risk of congenital cardiovascular defects associated with use of paroxetine during pregnancy.孕期使用帕罗西汀与先天性心血管缺陷相关风险的评估。
Am J Psychiatry. 2008 Jun;165(6):749-52. doi: 10.1176/appi.ajp.2007.07060879. Epub 2008 Apr 1.
8
Advancing women's health in the 21st century: applying the tools of clinical pharmacology.
Clin Pharmacol Ther. 2008 Jan;83(1):3-7. doi: 10.1038/sj.clpt.6100463.
9
Prenatal exposure to fluoxetine induces fetal pulmonary hypertension in the rat.孕期暴露于氟西汀可诱导大鼠胎儿发生肺动脉高压。
Am J Respir Crit Care Med. 2007 Nov 15;176(10):1035-40. doi: 10.1164/rccm.200701-163OC. Epub 2007 Aug 16.
10
Future of pediatric therapeutics: reauthorization of BPCA and PREA.儿科治疗的未来：《儿童用药优先审评法案》（BPCA）和《儿科研究公平法案》（PREA）的重新授权
Clin Pharmacol Ther. 2007 Apr;81(4):477-9. doi: 10.1038/sj.clpt.6100109.
Zotero 插件